Peter Kusher is listed as an executive officer and director on 1 SEC Form D filing by 1 issuer in Aug 2018: Olema Pharmaceuticals, Inc. (San Francisco, CA — pharmaceuticals — 2018; $250M reported sold to 27 investors).
What this means One deal on file with the SEC, filed Aug 2018. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Andrei Manoliu (1 shared filing), Andrew Rappaport (1 shared filing), Cyrus Harmon (1 shared filing), David Myles (1 shared filing), Frank McCormick (1 shared filing) and 3 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Peter. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 court cases matching the name, 1 bankruptcy case matching the name listed in Key records below.
What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Peter Kusher and found 1 difference: Form D filed 39 days after the first sale.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.